<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe</title>
    <description>Pharma in Poland - Polish pharmaceutical market reports and newsletters, profiles of drug distributors and manufacturers. Free articles &amp; sector news, market data and databases.</description>
    <link>http://www.pharmapoland.com/</link>
    <lastBuildDate>Wed, 08 Sep 2010 16:21:24 +0200</lastBuildDate>
    <image>
      <url>http://www.polishmarket.com/_i/images/PMR.gif</url>
      <title></title>
      <link>http://www.pharmapoland.com/</link>
      <width>100</width>
      <height>51</height>
      <description>Pharma in Poland - Polish pharmaceutical market reports and newsletters, profiles of drug distributors and manufacturers. Free articles &amp; sector news, market data and databases.</description>
    </image>
    <item>
      <title>75% sales growth for PZ Cormay in H1 2010</title>
      <link>http://www.pharmapoland.com/91619/75__sales_growth_for_PZ_Cormay_in_H1_2010.shtml</link>
      <description> PZ Cormay, the listed supplier and distributor of diagnostic reagents and equipment, posted PLN 30.8m (€7.7m) consolidated net revenues in H1 2010, up by a solid 75.4% y-o-y.&lt;/I&gt; ... </description>
      <pubDate>Wed, 01 Sep 2010 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>NFZ spent over PLN 1bn on therapeutic programmes in 2009</title>
      <link>http://www.pharmapoland.com/91617/NFZ_spent_over_PLN_1bn_on_therapeutic_programmes_in_2009.shtml</link>
      <description> The National Health Fund (NFZ) reported that in 2009 it spent over PLN 1bn (€249.7m) on therapeutic programmes, a measure of reimbursement for the most innovative and expensive&lt;/I&gt; ... </description>
      <pubDate>Wed, 01 Sep 2010 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Nepentes posts 24.5% net profit decline in H1 2010</title>
      <link>http://www.pharmapoland.com/91614/Nepentes_posts_24_5__net_profit_decline_in_H1_2010.shtml</link>
      <description> Nepentes, the listed manufacturer and distributor of dermocosmetics and medicinal products, reported a 0.8% y-o-y drop in group sales revenues in the first six months of the year,&lt;/I&gt; ... </description>
      <pubDate>Wed, 01 Sep 2010 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Neuca posts PLN 3bn sales in H1 2010</title>
      <link>http://www.pharmapoland.com/91610/Neuca_posts_PLN_3bn_sales_in_H1_2010.shtml</link>
      <description> Neuca, the leading Polish drug distributor, posted a 21% y-o-y increase in consolidated group  revenues to PLN 3.09bn (€0.8bn) in the first six months of 2010. The company’s&lt;/I&gt; ... </description>
      <pubDate>Wed, 01 Sep 2010 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Lux Med new one-day surgery hospital opens its doors in Warsaw</title>
      <link>http://www.pharmapoland.com/91601/Lux_Med_new_one_day_surgery_hospital_opens_its_doors_in_Warsaw.shtml</link>
      <description> Lux Med Group, the number one private healthcare provider by revenues in Poland, has launched a new one-day surgery hospital in Warsaw. The facility, built at a cost of PLN 20m (€5.1m),&lt;/I&gt; ... </description>
      <pubDate>Wed, 01 Sep 2010 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Sales of Grindeks increase by over 7% in H1 2010</title>
      <link>http://www.pharmapoland.com/91600/Sales_of_Grindeks_increase_by_over_7__in_H1_2010.shtml</link>
      <description> Grindeks, the number one Latvian drug maker, reported a 7.7% y-o-y increase in net sales revenues in the first half of the year, to LVL 32.1m (€45.7m). Net profit increased by&lt;/I&gt; ... </description>
      <pubDate>Wed, 01 Sep 2010 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Neuca increases its current account credit line </title>
      <link>http://www.pharmapoland.com/91321/Neuca_increases_its_current_account_credit_line_.shtml</link>
      <description> Neuca, a leading Polish drug distributor, has amended its loan agreement with bank Pekao SA in order to draw down a bigger sum on its current account, increasing the loan by PLN 15m (€3.7m)&lt;/I&gt; ... </description>
      <pubDate>Thu, 26 Aug 2010 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>National Health Fund increases healthcare budget in four voivodships</title>
      <link>http://www.pharmapoland.com/91320/National_Health_Fund_increases_healthcare_budget_in_four_voivodships.shtml</link>
      <description> The National Health Fund (NFZ) has issued four regulations amending NFZ’s 2011 healthcare budget in order to increase funding allocated to the provision of healthcare services&lt;/I&gt; ... </description>
      <pubDate>Thu, 26 Aug 2010 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>12.5% growth for pharmaceutical manufacturers revenues in 2009 in Hungary </title>
      <link>http://www.pharmapoland.com/91312/12_5__growth_for_pharmaceutical_manufacturers_revenues_in_2009_in_Hungary_.shtml</link>
      <description> The value of revenues of pharmaceutical manufacturers in Hungary has increased 12.5% y-o-y, according to the industrial data of the Hungarian Central Statistical Agency (KSH)&lt;/I&gt; ... </description>
      <pubDate>Wed, 25 Aug 2010 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Sanitas enjoys 19% group sales growth in Poland in H1 2010 </title>
      <link>http://www.pharmapoland.com/91300/Sanitas_enjoys_19__group_sales_growth_in_Poland_in_H1_2010_.shtml</link>
      <description> Sanitas, the Lithuanian drug maker, reported a solid improvement in sales revenues in Poland in the first quarter of the year.&#13;
The company, which owns Jelfa and Homeofarm, generated&lt;/I&gt; ... </description>
      <pubDate>Wed, 25 Aug 2010 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Enel-Med teams up with Allianz</title>
      <link>http://www.pharmapoland.com/91212/Enel_Med_teams_up_with_Allianz.shtml</link>
      <description> Enel-Med has signed a collaboration agreement with Allianz about the provision of healthcare services to holders of the German firm’s group health insurance policies, Allianz&lt;/I&gt; ... </description>
      <pubDate>Tue, 24 Aug 2010 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Telemedycyna makes strong stock market debut</title>
      <link>http://www.pharmapoland.com/91069/Telemedycyna_makes_strong_stock_market_debut.shtml</link>
      <description> Telemedycyna Polska, a provider of e-health services, has made a successful debut on NewConnect, the junior Warsaw stock market. Rights-to-shares in the company surged by 49% on&lt;/I&gt; ... </description>
      <pubDate>Fri, 20 Aug 2010 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Pharma companies continue staff recruitment </title>
      <link>http://www.pharmapoland.com/90960/Pharma_companies_continue_staff_recruitment_.shtml</link>
      <description> Despite the holiday season, only in August more than 20 pharma companies and outsourced headhunting companies continued to recruit in Poland.&#13;
&#13;
Countrywide, Krka is looking for&lt;/I&gt; ... </description>
      <pubDate>Thu, 19 Aug 2010 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>VHI premium revenues at Allianz up by 9% in H1 2010</title>
      <link>http://www.pharmapoland.com/90916/VHI_premium_revenues_at_Allianz_up_by_9__in_H1_2010.shtml</link>
      <description> The life-insurance unit of Allianz Polska posted a 9% y-o-y increase in premium revenues from voluntary health insurance (VHI) policies in the first six months of the year, the company&lt;/I&gt; ... </description>
      <pubDate>Wed, 18 Aug 2010 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Cormay in acquisition talks in US, upbeat about Q2 and H2 results  </title>
      <link>http://www.pharmapoland.com/90892/Cormay_in_acquisition_talks_in_US__upbeat_about_Q2_and_H2_results__.shtml</link>
      <description> PZ Cormay, the listed supplier and distributor of diagnostic reagents and equipment, is in advanced talks with an unnamed US maker of protein-specific reagents about a takeover,&lt;/I&gt; ... </description>
      <pubDate>Wed, 18 Aug 2010 00:00:00 +0200</pubDate>
    </item>
  </channel>
</rss>
<!--

		There was 4 queries

		
			CONNECT TO admin402@mysqls.polishmarket.serwery.pl;
			time: not available
			
			SET NAMES latin2;
			time: 0.00014305114746094
			
			USE baza402;
			time: not available
			
			SELECT id,	news_feature, title, content, date FROM arch_item WHERE news_feature = 1 AND dostepny = 1 AND new_category IN (37, 39, 40, 41, 68, 69) ORDER BY date DESC, id DESC LIMIT 15;
			time: 0.001230001449585
			

		Total script time: 0.010550975799561-->

